These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
822 related items for PubMed ID: 18413411
1. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Damián-Abrego GN, Cabiedes J, Cabral AR. Lupus; 2008 Apr; 17(4):300-4. PubMed ID: 18413411 [Abstract] [Full Text] [Related]
2. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ. J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741 [Abstract] [Full Text] [Related]
3. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study. Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gómez-García L, Vargas A, Bojalil R. Arthritis Res Ther; 2006 Jan; 8(5):R144. PubMed ID: 16934155 [Abstract] [Full Text] [Related]
5. Deforming Arthropathy in Thai Patients With Systemic Lupus Erythematosus. Lhakum P, Kasitanon N, Sivasomboon C, Wangkaew S, Louthrenoo W. J Clin Rheumatol; 2016 Jan; 22(1):1-7. PubMed ID: 26693619 [Abstract] [Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? Taraborelli M, Inverardi F, Fredi M, Ceribelli A, Cavazzana I, Tincani A, Franceschini F. Reumatismo; 2012 Dec 11; 64(5):321-5. PubMed ID: 23256108 [Abstract] [Full Text] [Related]
7. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S. J Rheumatol; 2006 Dec 11; 33(12):2390-7. PubMed ID: 16924694 [Abstract] [Full Text] [Related]
8. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A, Plischke H, Kellner H, Gruber R. Ann N Y Acad Sci; 2005 Jun 11; 1050():295-303. PubMed ID: 16014545 [Abstract] [Full Text] [Related]
9. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. J Rheumatol; 2004 Sep 11; 31(9):1829-33. PubMed ID: 15338508 [Abstract] [Full Text] [Related]
10. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M. Mikrobiyol Bul; 2008 Oct 11; 42(4):669-74. PubMed ID: 19149089 [Abstract] [Full Text] [Related]
11. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus. Popescu C, Zofotă S, Bojincă V, Ionescu R. Rom J Intern Med; 2013 Oct 11; 51(3-4):179-87. PubMed ID: 24620631 [Abstract] [Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Habib HM, Mosaad YM, Youssef HM. Immunol Invest; 2008 Oct 11; 37(8):849-57. PubMed ID: 18991100 [Abstract] [Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC. J Rheumatol; 2009 Apr 11; 36(4):712-6. PubMed ID: 19286846 [Abstract] [Full Text] [Related]
14. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, Segal MS, Hahn PC, Chan EK, Reeves WH, Satoh M. J Rheumatol; 2009 Dec 11; 36(12):2682-90. PubMed ID: 19884269 [Abstract] [Full Text] [Related]
15. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. Arthritis Rheum; 2000 Jan 11; 43(1):155-63. PubMed ID: 10643712 [Abstract] [Full Text] [Related]
16. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA. Arthritis Res Ther; 2005 Jan 11; 7(3):R592-603. PubMed ID: 15899046 [Abstract] [Full Text] [Related]
17. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP. J Clin Rheumatol; 2006 Aug 11; 12(4):172-5. PubMed ID: 16891919 [Abstract] [Full Text] [Related]
18. Deforming arthropathy in systemic lupus erythematosus. Pipili C, Sfritzeri A, Cholongitas E. Eur J Intern Med; 2008 Nov 11; 19(7):482-7. PubMed ID: 19013374 [Abstract] [Full Text] [Related]
19. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1]. Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Biomedica; 2004 Jun 11; 24(2):140-52. PubMed ID: 15495594 [Abstract] [Full Text] [Related]
20. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis]. Xie QB, Yin G. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May 11; 40(3):508-12. PubMed ID: 19627016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]